1103 related articles for article (PubMed ID: 20674596)
1. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
Harapanhalli RS
Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
[TBL] [Abstract][Full Text] [Related]
2. Operation of a radiopharmacy for a clinical trial.
Norenberg JP; Petry NA; Schwarz S
Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
[TBL] [Abstract][Full Text] [Related]
3. Instrumentation and radiopharmaceutical validation.
Zigler SS
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):402-10. PubMed ID: 19834450
[TBL] [Abstract][Full Text] [Related]
4. The radioactive drug research committee: Background and retrospective study of reported research data (1975-2004).
Suleiman OH; Fejka R; Houn F; Walsh M
J Nucl Med; 2006 Jul; 47(7):1220-6. PubMed ID: 16818959
[TBL] [Abstract][Full Text] [Related]
5. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
6. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
[TBL] [Abstract][Full Text] [Related]
7. Revocation of regulation on positron emission tomography drug products--FDA. Final rule; revocation.
Fed Regist; 1997 Dec; 62(244):66522. PubMed ID: 10179303
[TBL] [Abstract][Full Text] [Related]
8. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
9. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring--FDA. Proposed rule.
Fed Regist; 1998 May; 63(99):28301-9. PubMed ID: 10179873
[TBL] [Abstract][Full Text] [Related]
10. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative.
Cabell CH; Noto TC; Krucoff MW
J Electrocardiol; 2005 Oct; 38(4 Suppl):175-9. PubMed ID: 16226096
[TBL] [Abstract][Full Text] [Related]
12. Investigational new drug applications; clinical holds--FDA. Direct final rule.
Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
[TBL] [Abstract][Full Text] [Related]
13. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
Fed Regist; 1992 Dec; 57(239):58942-60. PubMed ID: 10123232
[TBL] [Abstract][Full Text] [Related]
14. Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance.
Fed Regist; 1998 Oct; 63(198):55067-9. PubMed ID: 10185833
[TBL] [Abstract][Full Text] [Related]
15. Regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 May; 64(94):26657-70. PubMed ID: 10558516
[TBL] [Abstract][Full Text] [Related]
16. Current good manufacturing practice for positron emission tomography drugs.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(236):65409-36. PubMed ID: 20169678
[TBL] [Abstract][Full Text] [Related]
17. Regulatory Requirements for PET Drug Production.
Schwarz SW; Dick D; VanBrocklin HF; Hoffman JM
J Nucl Med; 2014 Jul; 55(7):1132-7. PubMed ID: 24914057
[TBL] [Abstract][Full Text] [Related]
18. The role of the FDA in the effort against AIDS.
Young FE
Public Health Rep; 1988; 103(3):242-5. PubMed ID: 3131814
[TBL] [Abstract][Full Text] [Related]
19. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
[TBL] [Abstract][Full Text] [Related]
20. Efficacy considerations for U.S. Food and Drug Administration approval of diagnostic radiopharmaceuticals.
Gorovets A; Marzella L; Rieves D; Yang L
J Nucl Med; 2013 Aug; 54(8):1479-84. PubMed ID: 23749997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
